Review
The menopausal transition: how does route of delivery affect the risk/benefit ratio of hormone therapy?
Affiliations
- PMID: 15251108
Item in Clipboard
Review
The menopausal transition: how does route of delivery affect the risk/benefit ratio of hormone therapy?
J Fam Pract.
2004 Jul.
No abstract available
Similar articles
-
Hormone therapy. An update on risks and benefits.Mayo Clin Womens Healthsource. 2009 Mar;Suppl:1-8. Mayo Clin Womens Healthsource. 2009. PMID: 19405167 No abstract available.
-
A personal initiative for women's health: to challenge the Women's Health Initiative.Gynecol Endocrinol. 2002 Aug;16(4):255-7. Gynecol Endocrinol. 2002. PMID: 12396552 No abstract available.
-
Health risks after cessation of postmenopausal hormone therapy.Climacteric. 2008 Jun;11(3):179-80. doi: 10.1080/13697130802176228. Climacteric. 2008. PMID: 18568782 No abstract available.
-
[Phytoestrogens--an alternative to hormonal replacement therapy].Wiad Lek. 2004;57 Suppl 1:74-7. Wiad Lek. 2004. PMID: 15884209 Review. Polish.
-
Menopausal hormone replacement therapy.Curr Womens Health Rep. 2003 Oct;3(5):410-7. Curr Womens Health Rep. 2003. PMID: 12959701 Review.
Cited by
-
Transdermal hormone therapy and bone health.Clin Interv Aging. 2008;3(1):51-4. doi: 10.2147/cia.s937. Clin Interv Aging. 2008. PMID: 18488878 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical